Plus500 Ltd (PLUS)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 3,352.00 |
|---|---|
| 52-week range | 2,874.00 – 5,535.00 |
| Return, 1 month / 3 months | −5.0% / −16.1% |
| Return, 1 year / 3 years | +9.4% / +205.3% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 31.1% |
| Worst drawdown (1 year) | -35.3% |
| Average daily value traded | 555.85M GBX |
| Dividend yield | 5.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Plus500 Ltd runs an online trading platform that lets retail customers trade contracts for difference on financial instruments such as company stock, indices, commodities, foreign exchange and digital currencies. The company provides the technology, account services and customer support behind the platform, and earns money from the spreads and fees charged on trades. It is based in Haifa, Israel, and serves individual traders in many countries through localised versions of its service.
On this site Plus500 Ltd appears as a stock on the London Exchange (UK), code PLUS, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Plus500 Ltd (PLUS) trades on the London Exchange in UK. It last closed at GBX 3,352.00 on 22 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 2,325 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.4% and over the last three months it fell 16.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 19 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -17.4% | ||
| From 52-week high | -33.9% | ||
| Momentum | 33 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -16.1% | ||
| 6-month return | -23.9% | ||
| 12-month return, skipping the last month | 15.2% | ||
| Stability (higher is calmer) | 49 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.3% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 555.85M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.5% |
|---|---|
| 1 month | −5.0% |
| 3 months | −16.1% |
| 6 months | −23.9% |
| 1 year | +9.4% |
| 3 years | +205.3% |
| 5 years | +217.0% |
Signals
| 50-day / 200-day average | 3,508.26 / 4,060.17 |
|---|---|
| Golden / death cross (60 days) | Death, 33 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 110.60 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Aug 2026 | GBP 0.9003 |
| 19 Feb 2026 | GBP 0.9346 |
| 21 Aug 2025 | GBP 0.7917 |
| 27 Feb 2025 | GBP 0.9181 |
| 29 Aug 2024 | GBP 0.7502 |
| 29 Feb 2024 | GBP 0.7099 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.